(Q41442996)

30 September 2017

1 reference

title

Growth factors and renal cancer: characterization and therapeutic implications (English)

1 reference

30 September 2017

J H Mydlo

1

1 reference

30 September 2017

1 January 1995

1 reference

30 September 2017

World Journal of Urology

1 reference

30 September 2017

13

1 reference

30 September 2017

6

1 reference

30 September 2017

356-363

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00191217

30 September 2017

0 references

cites work

Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue

1 reference

12 December 2020

Interleukin-6 and renal cell cancer: production, regulation, and growth effects

1 reference

12 December 2020

Suramin as an archetypical compound in the development of growth factor antagonists for inhibition of genitourinary tumors

1 reference

12 December 2020

A pilot study of suramin in the treatment of metastatic renal cell carcinoma

1 reference

12 December 2020

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

12 December 2020

End stage renal disease serum contains a specific renal cell growth factor

1 reference

12 December 2020

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

12 December 2020

Analysis of growth factors in renal cell carcinoma

1 reference

12 December 2020

The effects of basic fibroblast growth factor and suramin on cell motility and growth of rat prostate cancer cells

1 reference

12 December 2020

A sensitive enzyme immunoassay for human basic fibroblast growth factor

1 reference

12 December 2020

Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma

1 reference

12 December 2020

Detection of tumor angiogenesis factor in adenocarcinoma of kidney

1 reference

12 December 2020

Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors

1 reference

12 December 2020

Inhibitory effects of suramin on a human renal cell carcinoma line, causing nephrogenic hepatic dysfunction

1 reference

12 December 2020

Truncated fibronectin. An autologous growth-promoting substance secreted by renal carcinoma cells

1 reference

12 December 2020

Conditioned media from a renal cell carcinoma cell line demonstrates the presence of basic fibroblast growth factor.

1 reference

12 December 2020

Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma

1 reference

12 December 2020

Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator

1 reference

12 December 2020

Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines.

1 reference

12 December 2020

Epidemiology of adenocarcinoma of the kidney

1 reference

12 December 2020

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

12 December 2020

Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma

1 reference

12 December 2020

Fibroblast growth factor

1 reference

12 December 2020

Problems in the radiologic diagnosis of renal parenchymal tumors

1 reference

12 December 2020

Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma.

1 reference

12 December 2020

Secretion of autocrine growth-promoting activity by renal-carcinoma cells treated with 5-fluorouracil

1 reference

12 December 2020

Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography

1 reference

12 December 2020

Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival

1 reference

12 December 2020

Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies

1 reference

12 December 2020

Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer

1 reference

12 December 2020

Renotrophic factors in urine

1 reference

12 December 2020

Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1)

1 reference

12 December 2020

In vitro evidence from tissue cultures to prove existence of rabbit and human renotropic growth factor

1 reference

12 December 2020

Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture

1 reference

12 December 2020

Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival

1 reference

12 December 2020

Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma

1 reference

12 December 2020

The biology of renal cancer: the influence of nephrectomy

1 reference

12 December 2020

A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC).

1 reference

12 December 2020

Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression

1 reference

12 December 2020

Growth factors in urologic tissues: detection, characterization, and clinical applications

1 reference

12 December 2020

[A study of the metabolism of vitamin D in patients with renal cell carcinoma--with special reference to serum concentration of 1 alpha, 25-(OH)2D and its clinical significance].

1 reference

12 December 2020

A study of growth factors in human renal cysts with or without renal cell carcinoma

1 reference

12 December 2020

Blockage of autonomous growth of ACHN cells by anti-renal cell carcinoma monoclonal antibody 5F4.

1 reference

12 December 2020

The Vascularization of Tumors

1 reference

12 December 2020

Human renal cancer carcinogenesis: a review of recent advances

1 reference

12 December 2020

Cytostatic effects of suramin on prostate cancer cells cultured from primary tumors

1 reference

12 December 2020

Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: the role of apoptosis.

1 reference

12 December 2020

Phase II trial of low dose gamma-interferon in metastatic renal cell carcinoma

1 reference

12 December 2020

Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney

1 reference

12 December 2020

Compensatory growth of the kidney

1 reference

12 December 2020

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

1 reference

12 December 2020

Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures

1 reference

12 December 2020

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

12 December 2020

Analysis of papillary renal adenocarcinoma

1 reference

12 December 2020

Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00191217

1 reference

PubMed ID

9116755

Dimensions Publication ID

30 September 2017

0 references

1 reference

PubMed ID

9116755